Delivery Order SPE2DB22D3401-SPE2DB24FT2JN

Award Date 3/25/24
Potential Completion Date 4/15/24
Potential Value $3.9K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a for-profit pharmaceutical sourcing and distribution company. The contract is for the supply of INGREZZA 40 MG CAPSULE 30S, a specialty pharmaceutical product, with a potential value of $3,553.31 and a completion date of March 25, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) awarded...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,553.31, is for the delivery of 4565242920 INGREZZA 40 MG CAPSULE 30S. The contract is a firm fixed-price delivery order with an ultimate completion date of August 14, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,676.12 firm fixed-price delivery order is for the supply of INGREZZA 40 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of March 17, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with...
This is a $3,553.31 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of INGREZZA 40 MG CAPSULE 30S, a prescription medication. The order has an ultimate completion date of March 14, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of INGREZZA 80 MG CAPSULE 30S, a pharmaceutical product. The contract has a ceiling value of $3,893.15 and a completion date of September 25, 2024. The contract is a Firm Fixed Price contract type. This order is part of a larger Indefinite Delivery Contract (IDC) that DLA Troop Support Medical has with AmerisourceBergen, valued at up to $999,999,999 through December 2025,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,834.53, is for the delivery of INGREZZA 80 MG CAPSULE 30S, a specialty pharmaceutical product. The contract is a firm fixed price, delivery order type, with a completion date of November 3, 2022. The contract was awarded on October 13, 2022 and was not set aside for any specific...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,083.10 firm fixed-price delivery order is for the supply of INGREZZA 80 MG CAPSULE 30S, a specialty medication. The contract has an ultimate completion date of January 8, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product INGREZZA 80 MG CAPSULE 30S. The contract has a ceiling value of $3,893.15 and a period of performance through April 8, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which was not set aside for any specific business type. The company also holds...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of INGREZZA 80 MG CAPSULE 30S. The order has a firm fixed price of $3,714.98 and a completion date of February 16, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to the pharmaceutical distributor Amerisourcebergen Drug Corp for the supply of INGREZZA 80 MG CAPSULE 30S. The firm-fixed-price contract has a ceiling value of $3,893.15 and an ultimate completion date of September 3, 2024. This appears to be a component of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
  • SPE2DB22D3401
    Indefinite Delivery Contract
  • SPE2DB22D3401-SPE2DB24FT2JN
    Delivery Order

This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract, valued at $3,893.15, is for the provision of a specialty pharmaceutical product, INGREZZA 80 MG CAPSULE 30S. This delivery order is issued under a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for AmerisourceBergen Drug Corp to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This contract award does not have a set-aside designation.

Generated 6/24/24, 9:20 AM